Trials / Completed
CompletedNCT06713278
Tension-Type Headache and Masseter Thickness in Fibromyalgia
Association Between Tension-Type Headache and Masseter Muscle Thickness in Women With Fibromyalgia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 94 (actual)
- Sponsor
- Ankara City Hospital Bilkent · Academic / Other
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study aims to investigate the relationship between tension-type headaches and masseter muscle thickness in women with fibromyalgia syndrome (FMS) and to explore the potential for new therapeutic approaches in the treatment of both headaches and FMS. Additionally, the study seeks to evaluate the impact of headaches on the quality of life in individuals with FMS. Does tension-type headache associate with increased masseter muscle thickness in women with fibromyalgia syndrome (FMS)? Does tension-type headache negatively impact the quality of life in women with FMS?
Detailed description
Fibromyalgia syndrome (FMS) is a chronic condition characterized by widespread musculoskeletal pain, fatigue, cognitive dysfunction, and tenderness, affecting approximately 5% of the global population, predominantly women. Central sensitization plays a key role in its pathophysiology. Tension-type headaches, the most common in FMS (59.01%), are associated with pericranial muscle sensitivity, anxiety, and reduced quality of life. Increased masseter muscle activity has been observed in tension-type headaches, but its relationship with FMS remains unexplored.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | masseter muscle thickness measurement | masseter muscle thickness measurement with ultrasonography |
| OTHER | scales | headache impact scale (HIT-6) Short SF-36 fibromyalgia total score widespread pain index symptom severity scale fibromyalgia impact questionnaire (FIQ) |
Timeline
- Start date
- 2024-05-15
- Primary completion
- 2024-12-02
- Completion
- 2024-12-02
- First posted
- 2024-12-03
- Last updated
- 2024-12-04
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT06713278. Inclusion in this directory is not an endorsement.